Doctors ask: how do patients feel when cancer treatment returns?
NCT ID NCT06050434
Summary
This study aimed to understand how soft tissue sarcoma patients feel when they receive the same chemotherapy drug (trabectedin) for a second time. Researchers wanted to measure symptoms, side effects, and quality of life directly from patients during this retreatment. The study was part of a larger registry but was stopped early, enrolling only 7 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOFT TISSUE SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Frankfurt Universitätsklinikum
Frankfurt am Main, Germany
-
HELIOS KLinikum Bad Saarow
Bad Saarow, Germany
-
HELIOS Klinikum Berlin Buch
Berlin, Germany
-
Uniklinikum Leipzig
Leipzig, Germany
-
Universitätsklinikum Tübingen
Tübingen, Germany
-
Universitätsmedizin Greifswald
Greifswald, Germany
-
Universitätsmedizin Göttingen
Göttingen, Germany
-
Universitätsmedizin Mainz
Mainz, Germany
-
Westfälische Wilhelms-Universität Münster
Münster, Germany
Conditions
Explore the condition pages connected to this study.